The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of interval cytoreduction and age in advanced-stage ovarian cancer: A GOG ancillary study.
Stuart M. Lichtman
No relevant relationships to disclose
James Java
No relevant relationships to disclose
John L. Lovecchio
No relevant relationships to disclose
Dennis Chi
Consultant or Advisory Role - Nycomed
William P. Tew
No relevant relationships to disclose
Michael A. Bookman
No relevant relationships to disclose
Andrew Menzin
No relevant relationships to disclose